|
Volumn 36, Issue 4, 2004, Pages 1173-1174
|
A major role for host MHC class I antigen presentation for promoting islet allograft survival
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD40 LIGAND;
CD40 LIGAND MONOCLONAL ANTIBODY;
CD8 ANTIGEN;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
ACUTE GRAFT REJECTION;
ALLOGRAFT;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIGEN PRESENTATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
GRAFT SURVIVAL;
IMMUNOLOGICAL TOLERANCE;
IMMUNOMODULATION;
IMMUNOPHARMACOLOGY;
IMMUNOREACTIVITY;
IMMUNOSTIMULATION;
MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION;
MOUSE;
NATURAL KILLER CELL;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PHARMACOLOGICAL BLOCKING;
PRIORITY JOURNAL;
T LYMPHOCYTE ACTIVATION;
ANIMALS;
BETA 2-MICROGLOBULIN;
DIABETES MELLITUS, EXPERIMENTAL;
GRAFT SURVIVAL;
HISTOCOMPATIBILITY ANTIGENS CLASS I;
ISLETS OF LANGERHANS TRANSPLANTATION;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
MICE, KNOCKOUT;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 2942635886
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.04.061 Document Type: Conference Paper |
Times cited : (8)
|
References (6)
|